Oorsprong van het eerstegraads netwerk van Bo Liang
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Shanghai Zhimeng Biopharma, Inc.
 Shanghai Zhimeng Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Shanghai Zhimeng Biopharma, Inc. is a clinical-stage biopharmaceutical company located in the resource-rich Zhangjiang High Tech Park of Shanghai, China. The Chinese company is committed to developing innovative drugs for the treatment of chronic hepatitis B (CHB) and severe neurological diseases with significant unmet medical needs. Founded in 2017, Zhimeng Pharmaceutical Technology Co., Ltd. is a biotechnology company dedicated to the development of drugs for the treatment of CHB and related liver diseases. The company was founded by Huan Ming Chen, Zhi Jun Zhang, and Bo Liang, with Huan Ming Chen serving as the CEO since 2015.
2
| Holding Company | Pharmaceuticals: Major | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Bo Liang via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|
Statistieken
Internationaal
Sectoraal
Operationeel
| Founder | 2 |
| Chief Executive Officer | 1 |
| President | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sterkste connecties
| Insiders | |
|---|---|
| Huan Ming Chen | 1 |
| Zhi Jun Zhang | 1 |
